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Article 4

frequently , thus prolonging his mother's natural infertility and ~ tponing
the arrival of the sibling who will displace him from his mot! s arms);
that babies come more frequently (I Y2 to 2 Y2 years) when p; ;ts enjoy
the energy of youth and less often (2 to 3 years or more) as r nts enter
their late twenties and thirties ; that with natural child-spal
through
breastfeeding, the inherent infertility of the human species w<
keep the
average family size to about four or five well-spaced childre1 1e 12 and
14-child families of a generation ago were usually associate(
th bottle·
feeding). We say these things not as preachers , moralists , o
mfessors.
but merely as physicians who care for our patients in thei t a! being .
In this way, we bring to bear on the solution of practica;
blems in
the lives of our patients our special knowledge, which is gr J ed in the
Church's teaching on the inherent benignity and universal u
cability to
human behavior of the natural law and , with God's help , we 1
save them
from self-destructive decisions.
There are so many other areas of medical practice wh ic: 1n truly be
enlightened by our faith: the care of the elderly, of the dying, < .mdicapped
restricti ve
newborns, of infertile couples. In all these cases , the seemi;
teachings of the Church actually liberates us and our patient , seek more
restrictions
humane solutions to difficult problems. Only by heeding th
·ul poisons.
which, like warning labels , keep us from administering h ~ 1
can we truly be healers - givers of wholeness - to our
1ents.
1ow enough
Such a mission is impossible to each of us alone . We cann
of what is truly good or harmful , of why it is so , and of how ' ;)mmunicate
our knowledge effectively to our patients, without the inst n Jn, counsel.
and encouragement of our fellow Christian and Catholic p ,1cians . This
the National
is the raison d 'etre of the Catholic Physicians ' Guilds and
Federation.
If you have a local guild , be active; if not , start one . To, 1tt le interest?
How many members does it take? ' 'Wherever two or three · 1 _1:athered._· ·
Read this journal; discuss it with your friends. Come to one ,_,f the nauona:
meetings of the Federation held each fall at various sites. For Ule past sev~ra
years , these meetings have been uniformly superb - nourish. ; for the mmd.
the emotions, the spirit.
" Pray always ."
-
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The Pill and Cancer
Kevin Hume

a Doc~or Hume, an Australian physician , prepared the following paper for

A seml~ar on family planning at the Academy of Science, Canberra ,
ustralwn Capaol Territory , in November , 1983, and updated it this past
summer for b!' · · L ·
h
pu tcatwn 111 macre Quarterly. He notes that the three studies
1
~ ~end of the paper, from the Centres for Disease Control Cancer and
,::~~ f!ormone s:udy are ofparticular interest to U.S. readers. They were
su
a~lable until after the paper was completed, so Doctor ·Hwne
mmanzed them as they are presented here.

The DES Problem
Diethylstilbestrol, although a synthetic estrogen, is not a steroid and has
:t~ncy only 1/_25 that of ethinyl estradiol, the estrogen most commonly
DES ~n the combmed estrogen-progestogen Pill. Nevertheless the story of
of or~~ very relev~nt in any examin~tion of the subject of the relationship
The c~:t~acept1~es and neoplast~c changes in women.
Puen R' bl_ned Pill _was launched m 1958 after very inadequate trials in
and ;r ICO 10 ~h~ m1~ 1950s and was given limited approval by the Food
lllainl ug AdmmlstratJOn (FDA) of the U.S. in 1960. The drug company
at Y responsible for its early promotion. G. D. Searle and Co .. conducted
remendous ad t. .
.
the p-111 10
.
ver 1smg promotiOn campaign and very soon women on
PFess
the U.S. were being numbered in millions . This put indirect
the FDA h· h h
h
tas reure on
w IC • w en t e extent of the thalidomide disaster
1
Ciutionve~ ed by the find~ngs of McBride in 1961, should have called for
the Fa ·.1 1 owev~r, the Pill got the green light and , on the reassurance of
in 19()~ §.Plannmg Association that it was safe, was introduced into Britain
Pili, eac.h mce t~en we have seen a succession of new formulations of the
Thedotoclalm~d to b~ "safe" and indeed "safer" than its pr~decessor.
onty a f e_of the mgred1ents has been progressively lowered till it is now
~._
ractlon of what 1.t
. h
. . I .
'lil\'e qu· 1 .
was m t e ongma Pill. Some of the ingredients
forrnulat:~~~ dlsappea~ed ~!together, as have the so-called sequential
COurse, is th · much ~all~d m the late '60s and early '70s . The. reason, of
at the Pill, m practice, was shown to be not so safe . While
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increasing animal experimentation was carried out to test n·.
eroids, the
real guinea pigs have always been the actual users, the wo n
1emselves.
Generally speaking, the victims have been young, healthy W<
, although,
needless to say, the casualty rate rose sharply in the ol?
e groups.
ted earlier,
The DES experience was very similar. However, a~ ~t
there has been more time to see the long term results, giV II
a foretaste
,Jleagues in
of things to come. DES was first synthesiz~d
Dodds ar
..) by Smith,
1938. Its most prominent use followed studies 10 1948 and
f threatened
who suggested that DES was benefici~l in ~oth t~e treatmC'
l previously
abortions and the prevention of abortions 10 patients whc
an estimated
had repeated pregnancy losses. Between the late 1940s and I 1
DES during
two to three million women (mostly in the U.S.) , were prescr
each sex to
their pregnancies , thereby exposing I to 1.5 million fetu s,
uccessful in
the drug. Later studies showed that DES was not ?nl ~
~ prescribed.
benefitting women suffering from the disord~rs for wh~ch I '
n, neonatal
but was actually associated with significant mcreases 10 ar
onsequence
deaths and premature births. In addition, serious long ter
of in utero exposure to DES have continued to come to
1t.
In 1970, Herbst and Scully reponed the occurren< (l f clear cell
years. The~e
adenocarcinoma of the vagina in seven girls, aged 14 to
.:h cancers JO
seven cases exceeded the total ~f all previously reporte
this age range. In 1971 , an epidemiologic study demom.! ~d the link of
vaginal clear cell adenocarcinoma to in utero DES ex p• re which had
occurred 15 to 20 years earlier. The FDA banned the ,e of DES in
pregnancy the same year. However, the legacy of in ute r u ES exposure

?Y

has continued to grow.
has been
Although the most serious side effect to DES-exposed d;, ..!hte rs
ch
the induction of neoplasia (with over 300 cases reported L•. to 1979), sune
·
daughters are also more likely to have m10or
vag 11 ·11 and .uten
. of
abnormalities. Their fertility is affected resulting fro m -th norma 1ltle\ al
.
. I mucus c f~el·t .' and Fcervl
anatomical development with
cerv1ca
II pian
incompetence, as well as structural abnormalities of the u terus and_ : r~lit .
tubes, leading to menstrual and reproductive dy sfunction . e. g. ~~" :rinatal
spontaneous abortion, ectopic pregnancy, premature del l\ cry a P
death.
.
However
·tal ia
In male progeny there has so far been no evidence of malignancy·
there have been structural developmental abnorma I .1t1·e~ 0 f the gemnded
. ep1d1dymal
. .
affecting the pems,
cysts an d un derd eve Iope d a nd undesce
testes. t
f h developmenl
The maior risk of DES exposure may turn out to be not o t. e
· 1 an d cer v1cal dl
squa0100
of clear :.~cell adenocarcinoma, but of vagma
1\t .
2·
· 10
· sue h case s is re po rte Y·noma·
metaplasia . The prevalence o f dysp Ias1a
.
. _t he_mcl
. 'den ce. of
carcl
whereas there is an esti_m_a~ed five-fold ~~crease
10
malignanCY
·
in-situ. with the possibility of a vast mcrease 10 squamous
DES a a
A case of a 23-year-old single woman. who was exposed 10 ted with
fetus and affected by cervico-vaginal adenosis and as a result presen
298
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~arc• noma-in-situ, was reported by Shepherd, Dewhurst and Pryse- Davies
m the British Medical Journal. 2 Of particular interest was the fact that she
was taking the Pill, resulting, in her case, in double exposure to estrogens,
albe:t 24 years apart.

At this time , there is no substantial evidence that DES taken during the
pregnancy has had an adverse effect on the health of the mother. However,
the well known epidemiologist, Dr. Valerie Beral and Linda Colwell ,
reported a link ·between the taking of DES during pregnancy and the
appearance 18 to 22 years later of breast cancer. 3 It is recommended that
women who have taken DES in pregnancy be s ubjected to regular breast .
checks and Pap smears associated with colposcopy.
. There have now been seven patients with vaginal clear cell cancer
~Jsco~ered in Australia ; six of these patients had a hi story of maternal
mgest10n of DES. In 1972 , the Me,dical Journal of Australia publis hed a
statement from the Australian Drug Evaluation Committee outlining the
danger of maternal DES therapy and also the risk of the DES content of
the "m~rning after" Pill. DES Referral Centres have been set up in Australia
-at Prmce Henry' s Hospital in Victori a and King George V Hospital for
Mothers and Babies in Sydney .
A_ recent study by Greenberg et al, s upported by a grant from the US
NatiOnal Cancer Institute, compared the incidence of breast cancer in 3 ,033
women
~ho had taken DES in pregnancy during the period from 1940 to
1
960, With the incidence in a comparable group of unexposed parous
Yiornen.~ They found a crude relative risk of 1.4 in the exposed group, which
had a slightly higher breast cancer mortality (relative risk 1.1) than in the
unexposed. The authors concluded that the incidence of breast cancer was
:erately but statistically s ig nificantly ~n~~eased in women given DES ,
we~e unable to exclude the poss1bll1ty that some unrecognized
COncomitant of DES exposure accounted for this increase .
The findings of this study showed th at DES-exposed women clearly
:ared_to be at an increased risk of breast cancer which, while less than
lloreassac1ated with a_ pos!tive family history of the disease , seemed to become
6lu pronounced With time and may prove to be of greater concern in the
~: The frequency of breast cancer among the controls in thi s study
-"''Pt!d after the age of 60 years, when the difference between exposed
unexposed women was most pronounced .
The long-term effects of DES exposure on mothers. daughters and sons
~ kno~n and there is a continuing need for well-documented and Jongng studies to identity new problems and increased health risks associated
exposure to DES , as well as to allay anxiety among DES-exposed
ns and their families.

one recent study, Depue et al noted that testicular cancer was more
nt _among males with intra-uterine hormone exposure (9 of I 06 patients
testicular cancer vs . 2 of 107 controls had been exposed to hormones).
ver, in thi s series, five of the nine exposed mothers had received oral
ne pregnancy tests and only two had taken DES . 5
' 1985
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Endometrial Cancer - The Oracon Story
The incidence of cancer of the endometrium in women ~el (
the age
of 50 years is quite low at 14 cases per 100,000 women. It IS r icularly
rare in this age group where there are normal .regul~r menstJ , cycles.
Those at special risk are the obese and the mf~rtJ!e and ~ cially in
polycystic ovarian syndrome and in women. havmg est.roge.. mducing
of these
tumors and failure of ovulation and dysfunctional ble~dm~ .
posed to
conditions produce a situation where the endometnum IS
prolonged stimulation by estrogen unopposed
progesterc:rna have
Women who ultimately develop endometnal ~denocaJ .
frequently shown signs of hypothala~c-pituitary-ovanan dysfi , Jn in their
nenorrhea
reproductive years, manifested as ohgomenorrh~a, hyper- or h
frequently
and polymenorrhea. These dysfunctional bleedmg p~ttern~ ?l
ne triad of
because of failure to ovulate, causing problems of mf~rtJh.t~
~ ients with
hypertension , obesity and diabetes is a common findmg H
endometrial cancer. 7
,
ong period
Estrogen, whether endogenous or ex~g~nous. may, ove.
of time, produce endometrial hyperplasia If not mterruptet· opposed by
Jenomatous
rogesterone. This entity has been shown to advance . t
hyperplasia, carcinoma-in-situ or
. ,ncer . Postmenopausal estrogen use has also been associated with tl , :currence of
endometrial carcinoma. The overall risk has been shown 1 . six-fold for
cr five years
estrogen users as opposed to non-users. Long-term use o
carries a 15-fold risk.
.
~
J in the U.S.
In 1963' sequential oral contraceptives were fi~st mar
re clearly the
Their use was promoted , in part, by an effort to Simul at~
one, as found
natural sequence of estrogen , followed by estrog~n-prog
during the normal menstrual cycle. The scheme mvol vec1 '-.ing 80 to 100
an estrogenmeg. of estrogen alone for 14 to. 16 days , followe~.
·ontent
varying
progestogen combination for five to SIX days, the progestoc
from as little as 3mg to 25mg. s
.
t
!he occurrence
Silverberg, Makow~ki and ~yon, m 1975 , first re~o: . -,equential oral
of endometrial carcmoma m young women ta f ·thers By June,
contraceptives. These reports were qu~ckly followed ~) .' ~triu~ had been
1976 30 cases of verified invasive carcmoma of the en c' 1'1d documented
'
a
identified,
occurring in women un der t he age o f 40 who
usedhasequential
type
history of oral contraceptive use. Twenty ~ad
d one patient used
preparations, nine had used combined form.ulatJOn s, ~~i als had used one
an unknown type. Nineteen of the ~0 usmg ~eque he .estrogen and 25
preparation containing 100 meg of ethmylestradJOI ~~~ted under the tra?e
mg of dimethisterone, a weak progestogen, and rna . d t the sequential
nam e of Oracon . Before further studies could be carne ohu 'market by the
· hd raw n from t e
oral contraceptives were voluntan·1 y wit
.
f
. the en d metnal
manu acturers. 9
b . d. sites m
Progesterone competes with estrogen for m mg

?Y

eventually~ endo~etn~

°
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cells and may reduce the estrogen-stimulating effect. The exposure of the
normal estrogen-primed endometrium to progesterone converts this tissue
to the typical secretory type seen during the luteal phase of the menstrual
cycle. This cyclic effect of progesterone prevents the normal proliferative
endometrium from progression to hyperplasia. The addition of a potent
progestogen to the estrogen produces a decidual pattern of endometrial
response with a tendency to atrophy rather than progress to hyperplasia .
This property of progestogens is used therapeutically in the treatment of
endometrial cancer, which , incidentally , has a good prognosis with a cure
rate of 90%. Depo-Provera, (Medroxyprogesterone acetate) , in large and
repeated doses , appears to be the drug of choice.
However, predictions that the simultaneous administration of estrogen
and progestogen might reduce endometrial cancer risk should be regarded
with caution . While they do reduce the incidence of endometrial hyperplasia,
there is no direct evidence that this applies to endometrial cancer as well. 10
All estrogens seem to increase endometrial cancer risk, irrespective of
their formulation or mode of administration. Initially it was thought that
conjugated or "natural'' estrogens , particularly estrone, were primarily
responsible for the association , but recent work has implicated synthetic
compounds such as DES as well. Similarly it was thought earlier that
estrogens were more hazardous when given continuously rather than
cyclically, but this, too, is unsupported by newer investigations. 11
The addition of a powerful progestogen may protect women in older age
groups who take estrogen for prevention of osteoporosis or prolongation
of the "youthful look " , but it introduces all the hazards of thromboem~lism, hypertension and myocardial infarction which characterize the
taking of the Pill by women in older age groups. The mortality rate
accompanying Pill use in this group is 22 per 100,000 wome.n and this
exceeds that of endometrial cancer by far. 12

The Pill and Breast Cancer
ofIn .1950, a trial was set up in England to evaluate the effects of large doses
. stilbestrol (DES) and ethisterone , a progestogen , on rates of fetal loss
10

P~egnant diabetic women. Eight women were allocated at random to
l'eceJve the hormonal treatment and 76 to receive inactive tablets. The aim
to. establish the efficacy of this treatment in reducing fetal loss , the rates
Wh1ch Were exceptionally high in diabetic women. Identical rates of
tmtaneous abortion (8%) and perinatal mortality (23 %) were noted in both
fi honnone and non-hormone treated groups. Similar results were obtained
women in a randomized trial of stilbestrol conducted in
~go. Tha~ both studies failed to show a beneficial effect of hormonal
honn ent dunng pregnancy did much to curb the administration of sex
l9fios~nes to pregnant women , although the practice continued during the

:;s

~non-diabetic

' 1985

301

''

.

In 1978, Bibbo and colleagues reported the results of the 25-::. · followup of the mothers who had participated in the Chicago-based
11. They
found an excess of breast cancer in the group treated with stilbest:
although
the difference was not statistically significant. 13
In 1980, Valerie Beral and Linda Colwell , who was involved i• ;: original
English trial , reported on the long term follow up of mothers 'Aok part.
1e overall
Information about all but four of the women was obtained (97 %,
1d Wales,
mortality was 4 .5 times that of comparable women in Englan
s , mostly
most deaths being from complications of diabetes. More tu,
sed group
benign , were reported in the hormone-exposed than the non-e
st disease
(14-18% and 2-3 % respectively). Four cases of malignant 1
t-exposed.
were reported in the hormone-exposed women and none in thC'
r evidence
Beral and Colwell concluded that these findings supported c
the latent
linking estrogen treatment and breast cancer and suggested
5 years or
period before the tumor becomes clinically apparent may 1
longer .
Vance and
In a commentary on the findings of Beral and Colw
\traceptives
Millington drew attention to the fact that most studies on oral
a decrease.
found no increase in breast cancer in Pill users and perhaps, e
ancer, such
However, they pointed out that a delayed appearance of bre3
use younger
as that noted byBeral and Colwell , might have been missed b
women predominated in these investigations . They were pror ~d to review
these studies and prepared a table summarizing data from f1 ._:ase-control
studies of breast cancer according to "young " and "o ld " ~ ,; roups. Age
categories differ among studies and for two studies , the) 1 esumed that
I -I
premenopausal patients were younger than postmenopau
The data in their table indicate an increased risk of brea• a ncer among
women with a positive hi story of oral contraceptive use, bu .nly after they
have passed into their fifth or sixth decade. Most Pill usl have not yet
reached the critical age.

Relative Risk of Breast Cancer in Women with a · Iistory of
Contraceptive Use Compared with Controls in Pub li.., hed Studies.

Definition (y)

No. of cases

Rela tive risk

Reference

Young

Old

Young

Old

Young

O ld

1
2
3
4
5
5

15-39
pre
16-40
pre
31-45
31-45

40-49
post
46-50
post
46-55
46-55

104
126
301
768
31
23

348
160
115
1090
24
26

0.72
0 .80
0.8
1.09
1. 2
0 .8

1. 3 1
1.66
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2.4
1.24
3 .2
8.0

-

oc use
Ever
Ever
Ever
Ever
Past
Present

--

~reast cancer is more common among women who have neve r borne
children than among parous.women and the longer a woman delays her first
pregnancy; the more she mcreases her risk of developing the disease
Recently, It has been suggested that prolonged use of oral contraceptive~
before the first ~ull-term pregnancy may increase the risk of breast cancer
although after thts pregnancy the risk is probably unaffected by taking the Pill:
. Clearly , the first full-term pregnancy does something to alter a woman ' s
~tsk of developing breast cancer. Whether or not she breastfeeds is probably
I~elevant, but there is good evidence that the breast epithelium is permanently
changed .by pr.egnancy. Although histological change occurs in the ductules
t ehphysiOlog.tcal change in the epithelium, shown by its altered respons~
t~ ormones , IS more striking. Possibly the high progesterone concentrations
0 1
~te pregnancy induce progesterone receptors which can then respond
1
: . e lower concentrations of a normal menst rual cycle. If these receptors
the madequa~e before the first full tetm pregnancy ' then during normal cycles
e breast wtll therefore be exposed to " unopposed " estrogen despite th~
presence of nor 1
·
.
'
The
rna co.ncentratiOns. of progesterone m the circulation. Is
w
effe~ts of the .Pill may be dtfferent among nulliparous and parous
~men ~~ Is n~w bemg suggested by epidemiological surveys. Although
t~ed Pill provides estrogen balanced by progesterone if the breast
Of thcom
e nulltparous woman cannot respond to the progesterone' component
the n a young g · I t k'
h p· ·
·
'
"uno
tr a mg t e til IS exposmg her breast epithelium to
,
0
PP sed estrogen , although in a low , but steady concentration
Ea 1
· and late menopause are also
'
fact r Y. men arc he, nu 11·tpanty
important ri· sk
beg?rs Ihn the development of cancer of the breast . The sooner the cycles
In, t e sooner the "
· to act on the breast
epithel'
unopposed " estrogen begms
1
cycle mm_ . n the p~emenopau se, there is an increased frequency of anovular
asy ts, agam exposmg the breast to " unopposed" estrogen. A further but
e unconfirmed · ns
· k "tactor, IS
· that tdenttfied
·
· · by Prke
. and colleagues
'
n....
..... ue1Y an early ·
·
b
'
rnn~
. .
ffiJScarnage efore the first full-term pregnancy . Although
:-"''cntrattons of both t
d
.
.
In the nulli
es rogen an progesteron~ mcrease m early pregnancy '
having first~~;ous w~.man only the. estrogen wtll .affect the breast. Women
Were shown mester. m?uced abo~JOns ~efore their first full term pregnancy .
In the R.C.to be stmtlarly at ~Isk~ ~~th a .2.4-fold increas~.16
to breast can G.P. study of the ~Ill, Initiated m 1968 , the findmgs in regard
of breast
cer were reported 1n 1981 . 17 One hundred thirty-three cases
of the p·ucancer w.e re recorded . There were 19 deaths among ever-users
1
in the in .dand IO m the controls. Analysis showed a significant increase
if they h~d e:e of breast ca~cer among women aged 30 to 34 at diagnosis
- 6ll w
er used the Pill. By 1979 , less than 5 % of the original 23
for how ;men- were current , if intermittent users. No figures are given
or had us~n\of t~e 18 ,755 women , enrolled when they were already using
llseof the p ·ut e Pill , had developed breast disease during their previous
This previo~s' thought to amount to 25,570 women years (R .C.G .P. 1974) _
been obser du.se was excluded from the final analysis because it had not
ve tn use.

1
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In 1981 , Pike et al collected records of 293 women with b1 .;t cancer
under the age of 33 between 1972 and 1978; 48 had died an< r' the 163
interviewed, 83% had used the Pill. Those who had taken it fore their
first full-term pregnancy had an increased risk which rose with : duration
5 women
of Pill use. 18 In 1977 , Passenbarger et al found that 15 out l
19
under the age of 30 with breast cancer had used the Pill.
Pike also found a significant increase in breast cancer in •men with
a history of benign breast disease. Hoover eta! , in 1976, fou nc tt estrogen
ign disease
use was related to an especially high risk of breast cancer if the
developed after the women had started the drug. 20 The fi1 .g of large
as always
epidemiological trials that the Pill reduced benign breast di se
ved
just the
seemed anomalous to some clinicians whose observations s
opposite. 21
·
1 the British
The study of Pike et al gave rise to extensive corresponden
Medical Journal, especially challenging their concept of the lassification
tat of Swyer
of oral contraceptives according to "progestogen potency"
liology
does
is typical. However Swyer said: "My competence in epi
not allow me to criticize the general contention by Pike et < at long-term
isk of breast
use of oral contraceptives by young women may increase t
cancer . . . "

22

Meanwhile, the FDA , having reconsidered its posi t about oral
no increased
contraceptives and cancer, made a firm statement that the1
.1tegory
or in
risk of breast cancer in oral contraceptive users of an:
:
ptives.
association with any particular formulation of oral cont·
However the FDA felt somewhat uneasy about Pn ;sor Vessey's
1traceptives to
findings. It was planning to revise the labeling of oral
increased risk
include a warning that their use may be associated with
of cervical cancer. 23
More recently , a group of Swedish researchers has al! :l its su~p~rt to
the findings of Professor Pike and his Los Angeles grou: n a prehmwar~
0
report of a study about to be published. A case control ,.: dy was done d
80 consecutive cases of breast ca~cer in women .born .ir •: 39 or lat~~ a~y
diagnosed at the age of 45 or ear her, who were mterv1e , d persona Y
their physician. These were matched with 225 control'
.
..
· .. ·c regress1o 0 '
When the data were analyzed by cond Itwna1 1ogandl ml
. es
women who had started to use the Pill at 20-24 years of age had three;n~th
the risk of developing breast cancer prior to 46 years of age compare WI
non-users . .
. .
.
.
.
p·Jl wornen
The relative nsk mcreased with earher age of startmg the 1 · . risk
beginning to use the Pill after their first preg?a~cy had a lo~e~rel:!;v;tion,
than others, although the difference was not sigmficant . In thts wv:ncg were
both a low age at menarche and a high age at first full -term pregn Y
related to increased breast cancer risk.
.
ier reports
The authors conclude: "Our results, taken together wtth earl
ncern
linking early O .C . use with breast cancer, are a matter of great co
24
in respect of 0. C. use by young women''.
Linacre QuarterlY
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The Pill and Liver Tumors
The association between taking the Pill and the development of nonmalignant liver tumor hepatoma was first suggested in 1972 by Horvath. 25
The following year, Baum et al described seven women , all oral contraceptive
users, who developed benign hepatic adenomas . 26 Subsequently a number
of reports have appeared supporting these findings , although the
histopathologic . diagnosis has been variously reported as ·focal nodular
hyperplasia, adenoma, hamartoma, benign hepatoma , solitary hyperplastic
nodule and focal cirrhosis. Prior to 1970, benign liver tumors in young
women were very rare.
Th~ risk of developing these liver conditions increases dramatically with
duratiOn of use of the Pill , particularly after 5 years. The majority of affected
women had been taking mestranol-containing compounds , mestranol being
a. sy~thetic estrogen metabolized in the body to ethinylestradiol. Nevertheless
stg?Ificant numbers of these lesions have been reported in patients taking
etht~ylestradiol-containing compounds. A few patients have taken DES,
conJu~ated equine (natural) estrogens and progestogen-only compounds .
Bemgn hepatoma is a very vascular tumor ?- 'ld subject to spontaneous
rupture, death often resulting from massive hemorrhage. A carefully
conduc~~ national survey , carried out by the American College of Surgeons '
CommiSSion on Cancer , showed the frequency of benign lesions indicated
~large peak in the 26 to 30-year age group . This peak corresponds to the
mcreased use of oral contraceptives in this age group. The increase is true
only for Pill users and benign lesions. Vana et al in another study showed
~at 40% of tumors were diagnosed in women exposed for five years or
ess. ~emorrhage was most frequently associated with adenomas and almost
exclusively confined to the oral contraceptive users. A significant number
~fpatients present with signs of intraperitoneal hemorrhage and shock , the
estons seeming most prone to rupture at or about the time of menstruation .
A nun:tber of the reported deaths have occurred secondary to attempts
at resection . For those lesions which are asymptomatic , the best and safest
course would appear to be to discontinue the Pill , urge the patient to avoid
:;gnancy and await spontaneous resolution of the lesion . Pregnancy , with
effi resultan.t high levels of sex steroids , may have a particularly stimulating
ect. a~d mcrease the propensity for these lesions to hemmorhage . 27
1
~dtvi~ua.l case reports have appeared in the literature , particularly in
and et, linkin~ oral contraceptive use, some compounds containing mestranol
Fo ?thers ethmylestradiol, with malignant liver tumors in young women .
21 ri~stance, two cases of cholangiocarcinoma in women on the pill, aged
~- 2? years respectively , were reported. This malignant tumor has its
An Incidence in the sixth decade, being very rare in the third. 28 · 29
care· adde? ~isk factor in the development of primary hepatocellular
Afri tnoma IS mfection with hepatitis B virus which is endemic in Asia and
chil:~ ~evertheless this liver malignancy is rare among . women of
nng age (15-40) in Singapore. However Chong-Jin Oon eta! from
Nc,yember, 1985
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the Hepaioma and Liver Study Group of Singapore General Hospit reported
ad been
primary hepatocellular carcinoma in a 29-year-old woman wh
on two different formulations of the Pill (both containing ethiny stradiol)
for seven years. They considered the administration of the Pil l 1ay well
have res11lted in the earlier development of primary hepatocellular 1rcinoma
in this case. 30

The Pill and Malignant Melanoma in Australia
Valerie Beral and her associates have reported on a case co rol study
of287 women aged 15-24 years with malignant melanoma and 5 matched
controls conducted in Australia .
raceptive
Their findings indicated that, after a lag of I 0 years , oral c
use for a total of five years or longer was associated with a 50 increase
in risk . This relationship persisted after adjusting for a number · potential
confounding factors , including complexion , sunbathing activities .ccupation
and education. ·
Beral et al note that relative risk estimates reported by the i study and
several others which considered long term use of the Pill , were the range
of 1.4 to 4.4. While these relative risks were not large , they e re of the
same order of magnitude as the relative risks for blond hair colo t RR = 1.6)
or fair skin (RR=2.1), noted · by them for Australian women
oth these
factors are widely accepted as being important determinants o f elanoma.
In conclusion the authors state: ' ' If, as our data and that of otl rs suggest.
a lag period of 10 years or more is involved , it may still be se'h .-a! decades
before the effects of oral contraceptives on malignant mel a n ,rna can be
properly evaluated . " 3 1

The Pill and Cancer of the Cervix
One of the most fascinating stories of modern medicine i~ the gradual
unfolding of the epidemiology of cancer of the cervix. Wh ile ultimatelY
linked with the intricacies of behavior (perhaps misbehavior wo uld be the
better word) of human beings in regard to sexual activity and the not·
unexpected influence of sexually transmitted diseases, the Pi ll has managed
to find its way into the labyrinth , together with the ubiqui tous ciagrette.
While the epidemiological jig-saw is not yet complete, enough pieces have
been fitted into the picture to provide a good idea of the general landscape·
It is an ill wind that blows no one any good. We have to thank th_e ad~en:
of the Pill for the tremendous stimulus it has provided to epide mwlogtc:
research and the crop of outstanding researchers who have ri sen to 1 e
occasion in elucidating its many ill effects and its occasional hea lth benef~s . .
~he accompanying rise in_ sexually ~ransmi~ed d~seases ~as prov ided anot ~~
nch field for research w1th many mterestmg d1scovenes . All of whtch.
pays one to reflect, has been an expensive ongoing exercise . Chasti~y rna,:
in the eyes of modern liberated humanity , be a very dull virtue . but tt co
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effectiveness is undoubted. It also sets the standard in public health and
preventive medicine. Its cost to the taxpayer is nil, in sharp distinction to
the legacy of sexual liberation. While it may be cynically pointed out that
it is simply a case of a virtue bringing its own reward, it should be considered
worthy of a civic award - perhaps even a Nobel prize.
The suggested solutions take no account of the possibility that the
promotion of chastity may provide the answer. No, man ' s ingenuity will
find a way by producing some marvelous new polyvalent vaccine, dealing
a death blow to gonorrhea and syphilis, as though they were as controllable
as diphtheria and tetanus. Among the ranks of man ' s brilliant modern
rese~r~hers is waiting another Salk or Sabin who can produce a vaccine
toehm~nate the villainous Herpes virus II and its partner in crime, the genital
~~VIrus. Chastity, like modesty, is a term soon to be dropped from the
d1cttonary as obsolete, belonging to the Victorian era of sexual suppression
and frustration. Sexual liberation is here to stay , a much-venerated sacred
cow. It is unthinkable that it be open to challenge. Yet all the findings point
t~ sexual promiscuity as the culprit in the epidemic of pelvic inflammatory
~tsease, of herpes genitalis, of cervical neoplasia and even of acquired
Immune deficiency syndrome - AIDS.
Up till about 30 years ago , mortality figures for endometrial and cervical
~ancers were combined for statistical purposes. Only since that time has
11 ~n possible to study cervical neoplasia in any detail. There are two
pnnc1pal hypotheses considered in the etiology of cancer of the cervix :
(I) the association of cervical. cancer with factors related to an early age
at fi•rst ·•~tercourse and first pregnancy. It proposes that d:1ring adolescence ,
~ cerv1cal epithelial cells are especially vulnerable to carcinogens (the
oppleson theory).
2
/ > the association of cervical cancer with factors related to ~he multiplicity
0
sexual partners, not only of the woman herself but also of her husband
r:~po_sing that malignant change is induced by a sexually transmitted
ectJon. Herpes virus type II , the cause of genital herpes , has been long
:garded as the specific agent. 32 However, more recently , human papilloma
lrus, responsible for genital warts , has been joined with the herpes virus
as a cofactor. 33

~nc_er o~

the uterine cervix is almost unknown in nuns . The list of

~ rruolog1cal factors associated with cancer of the cervix have been known
~number of years. They constitute a formidable list indeed: broken
act' _age, multiple marriages , extramarital sexual activity , premarital sexual

ifk!IVJty, early age of first marriage, early age of first intercourse , multiple
rnu~~~ abortions, illegitimacy, multiple sexual partners of the woman,
e sexual_ partn~rs of her husband, history of prostitution , history of
On transmitted d1sease , low socio-economic status, and urban residence.
rest . 1. e other hand, common denominators of the low risk groups are:
~ct•~e codes of_se~ual conduct (chastity) , and religious endogamy , e.g .,
A. w 0 marry Wtthm their religious faith , particularly of the Jewish faith .
study of 750 Taiwan prostitutes by Sebastian et a! provided strong

se"Jh
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support for Coppleson' s theory . 34 Their women su.bjects did ~t
trade until they were aged 18 . They showed a low y1eld of cerv H
of 10 .7 per 1 ,000, indicating that it is sexual activity du~ing th
phase of active metaplasia which predi.sposes t? cervical d:
neoplasia . Many authors feel that there IS a contmuui? betwe
and neoplasia , including invasive cancer of the cerv1.x.
A new hypothesis of the etiology of cancer of the cervix has b
3
by Skegg et al , underlining the importance of the ~ale f~ctor.
point out that concentration on female sexual behaviOr fatls to e
epidemiological features of cervical cancer, e.g ::
.
1. the extremely high incidence in parts of Latm Amenca
chastity before marriage and fidelity within marriage are hi[
some of these societies;
2 . the large decline in mortality in many western co~ntrie'
half century or more which started long before screenmg p r

tart their
Jysplasia
iolescent
[asia and
dysplasia
proposed
1e authors
tin several
~ re

female
valued in

e r the past
ams began

in 1965;
3. the low risk in Jewish women;
4. the association with cigarette smoking, which appears to l 1dependent
of sexual risk factors, and
5. the possible association with oral contr~cepti.ves.
If cancer of the cervix is eaused by . an mfect1ous age transmitted
be of great
venereally the sexual background .of each ma~e partner ~ ~
la-in-situ in
importance. In one study of cervical dysplasia and car~n
·sk increased
women who claimed to have had only one partner, the relat1v
he husbands
with the number of sexual partners their husbands reporte
of affected women were also more likely to have had vene J disease, to
have visited prostitutes and to have had affairs during m ; tage.
In some Latin American societies, women are expected tt ave ~nly one
h ehavwr was
partner , whereas their husban?s. m~y h ave ~an~ · S uc
:
vors the
characteristic of European societies m th.e V1cton~n ~ra .d. fa h have
flouri shing of prostitution . Cali in Colombia and Recife m F tz!l bot . d
· ·
h ' h •r than Umte
incidence rates of cervical cancer f 01.1r to s1x times 1g t
fi . cy
Kingdom registries . It has been suggested that this could be c' uc ~o de !CI~n en
of Vitamin A in South American countries. Howev~~ prostl'Ution h~s ;en
a prominent feature of life in these countries and VISits to r .. othels . Ytheir
10
may account, at least in part, for the high risk of cervical ..:ancer
wives.
. .
.
.
h
terized the
The decline in mortality m cervical cancer, which has c arac b ween
·
·
d t ·
men born et
,
present century' was mterrupted by mcrease ra es m wo . . e 1939-4'
1911 and 1926 who spent part of their early adult lives dunn g th d ' 'the
war when th~ incidence of gonorrhea was high. This sugge~te es in
re;ence of an infective agent which was increased by the c angh , 36
P
.
h b
b
d its aftermat ·
customary sexual partnerships broug t a out Y war ~n
f sexual
0
The general decline in mortality may involve changmg patt.erns mbled
behavior in men from Victorian and Edwardian patterns w hich rese ctard··
.
.
h
h
·
" double stan
those of contemporary Latm Amenca w ere t ere IS a
rterlY
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of sexual morality with much resort by men to prost itutes .
In contemporary western society, the so-called permissive soc iety, marked
by increasing premarital sexual activity , particularly in women -both me n
and women tend to have several sexual partners. C e rvical cancer mortality
rates in young women have begun to rise again, at least in Britain and New
Zealand.
Another important etiol ogical factor is related to the husband's occupation.
There is a high mortality in the wives of men in spec ific occupations which
involve travel and absence from home. There is also evidence which suggests
that, if cervical cancer develops in a man ' s first wife , hi s sub seque nt wife
may be at an increased risk. This might reflect transmission of a virus from
the male , the identity of which virus is as yet unknown .
Malignant di sease is the most common cause of death in women aged
25 to 50. While the immediate effect of the Pill on vascular disease was
~ccepted fairly quickly , the increased risks of malignant disease and mental
lll.ness have taken longer to be acknowledged and quantified by large scale
tnals. 37 In the Oxford/ F.P .A. contraceptive study of 17 ,032 women aged
between 25 and 39, there were twice as many deaths from neop lasms (25.3)
as compared with circulatory disorders (12 .3). 3 8 , 3 9
A 1978 report of thi s same study was entitled "Neoplasia a nd dysplasia
0 ~ the cervix uteri and contraception: a possible protective effect of the
~1aphragm". Sixty-five of the women developed cervical neoplasia , the
mcidence rate in diaphragm users bei ng 0 . 17 per I ,000 women years of
?bservation as against the much higher rates of0 .95 in Pill users and 0.87
10 those fitted with an I. U. D. All s ix women who developed invasive cancer
h~d been using the Pill at the time of entry to the study . For the first time,
~Iga~ette smoking was reported as a major ri sk factor in cervical neoplasia
In th1s study. Al so, as compared to Pill and IUD users , diaphragm use rs
were less likely to have had coitus at an early age and had had ntaterially
fewer sexual partners . 4 0
ln. 1980, Harris et al showed that the ri sk of cervical dysplasia or
ca.rcmoma-in-situ increased with duration of Pill use, while the risk decreased
w;th prolonged use of barrier methods . They also found that the number
0
pa~ners exerted effects independently of age at first intercourse . Cigarette
smok~ng once again showed up as a significant risk factor. 41
Meissels et al, in a study of French Canad ians in Quebec , found in 2,017
~omen with mild and moderate dy splas ia highly significa nt correlations
fl tween early age at first coitus and oral contraceptive use . When corrected
or age at first coitus, there was a significant excess of dysplasias in Pill
~~~r Dys.pla~ia of ~he u~erine cervix beh.a ves epidemiologica~ly like
w dnoma-m-s1tu and mvas1ve squamous ca rcmoma, they stated-m other
atf~ s, es~entially as a venereal di sease . It remained to be seen whether
si rplaslas form one continuum or whether there are two morphologically
ffil ar. but biologically di stinct forms of dy splasia - one more frequent,
~~ssmg SJ?Onta~eously; the other relatively rare , progressi ng to carcinomau and mvas1 ve carcinoma of the cervix. 42
ovember , 1985
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Stern et al, in a study of 300 women with cervical dysplasia
>mpared
to 300 with negative smears, found that those using the Pill had
increase
in both severity of dysplasia and in the incidence of co!".version to
·cinomain-situ. The probability of progression from dysplasia to cancer
' ill users
was 0.3 after seven years, compared with 0.05 in non-users.
ad used
In the American Walnut Creek study of 16 ,638 women, 6 1
e major
the Pill while 50 % of those aged 50 to 54 had taken estrogen
d to only
cause of the 170 deaths were malignant neoplasms (45 %), comr
nificantly
15 % of deaths due to vascular causes. Cancer of the cervix was
nas were
increased for those under 40 years of age. Malignant mela
significantly increased as was lung cancer. in Pill users who
1ked . All
six cases of urinary tract neoplasms and SIX of the seven th )
J cancers
occurred in users.
.~ 6 to 15.2
Registration rates for carcinoma-in-situ have increased fro n
he largest
per 100,000 between 1965 , when registration began , a~d 197 ~
134
group
increase in new cases is in the 15- to 24-year-olds (ten times) 2
.1
res
show
(five times) and in the 35- to 44-year-olds (twice). These
cal
cancer
considerable increases in the incidence of both breast and ce
since the early 1960s when the Pill was introduce~ . . estrogen
" replacement" therapy became fashionable. The larg~st ~n c 1 , e is in the
of cancer,
15- to 24-year-olds who, although they still have a low mc~d e t
..:
Pill . This
have only recently become the main age group to start usmg
mes
. Their
age group has a risk of double exposure to exogenou~ h01
the
mini.
,
mothers may have taken them during pregnancy or lactatiOn (1
44
Pill or Depo-Provera) .
A very recent study by Holst and Abyholm 45 lo~ked at a ·oup of318
women with tubal infertility in Norway. Women w1th tubal fertility due
to pelvic inflammatory disease tend to have many of the ri sk tctors which
characterize women who develop cervical neoplasia. Th i rt ~ nne ~f th.ese
women (9. 7 %) had dysplasia of varying degree or ca re ' ~a-m-sl~
Fourteen (4.4%) had severe dysplasia or carcinoma-in-sit u Th1s was
times the national average for women in the age group f2t' 39). Amon~
200 unselected infertile controls, one patient had moderat and one sevher
• &
·1··.
The aut ors
1t • .
dysplasia. Both of these were found to have tubal m.ertl
conclude therefore that women with tubal infertili ty represe~t as
'
' group for the development o f precanc e rous lesiOn
comparatively
high risk
of the cervix.
nd 1977
In the U.S.A. the use of the Pill fell by 25 % between 1974 a
hod
46
but increased by 25% in the U .K. The Pill is the contraceptive me~ of
of choice for young unmarried girls who are now at much g rea~~ ~~~ned
becoming promiscuous than they were 2.0 year_s ago and havmgmatbabies.
pregnancies , abortions , sexually transmitted disease and abnor
a rs
The prestigious medical journal, Lancet, is noted for the number ofp ~of
· th.e media becaus
it has published which have aroused a fu ror ~n
h Lancer
consistently dramatic discoveries concerning the Ptll 's Ill effects. T ~ Prof.
on Oct. 22, 1983 , published not one, but two such papers, one Y
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M.C. Pike and his group in Los Angeles 4 7 on breast cancer and the Pill
and the other by Prof. Martin Vessey and his colleagues on the possible
adverse effect of the Pill in cervical neoplasia. 48 The reaction of the media
and of medical leaders in the field of family planning to this ' 'bombshell''
was characteristic - one of startled dismay and , in the case of many of the
doctors , disbelief. In fact both studies confirmed evidence which had been
mounting for some time .
As these papers were published when mine was well advanced I shall
deal with them both at this point as what one might call a Stop Press item.

The Breast Cancer Study

~ike and his colleagues carried out a case-control study of 314 breast cancer
patients aged less than 37 years at diagnosis and 314 individually matched
controls to assess the influence of the Pill on the risk of the disease. They
foun~ t~at long term use of the Pill , before age 25, of the combination type
c~ntam1?g a "high" content of the progestogen component, was associated
Wtth an mcreased risk of breast cancer. The relative risk was approximately
f~ur after five years of such use , and nine cases and no controls had used
Pills o~ this type for more than six years before age 25.
Prev10us studies of this type had few data on long term Pill use before
the .first full-term pregnancy.
Pike et al postulate that , as the combination Pill suppresses ovulation
~
.
'
ere IS a lack of rupture of the s·urface of the epithelium of the ovary and,
hen~e, a decrease of mitotic activity in this area where ovarian cancer arises.
A Similar lack of activity characterizes the effect of the Pill on the
enfdometrium, the peak of mitotic activity taking place in the follicular phase
0 the normal cycle .
1 In the breast , the reverse occurs, mitotic activity reaching a peak in the
uteal phase due to the effect of progesterone acting in combination with
estrogen. Combjnation oral contraceptives , with their mixture of estrogen
~rogestogen, may therefore stimulate breast tissue mitotic activity. The
~- .r the estrogen and progestogen content of the Pill , the greater the mitotic
at IVJty and hence the increase of risk of breast cancer. If Pill use begins
thean early age, when long and frequently anovular cycles are still common,
fi n the longer the time and the more intense the stimulation before the
Irst pregnancy.

e Th~ authors point out that the use of the Pill during similar cycles
. xpenenced during the pre-menopausal period is also associated with
Increased risk of breast cancer. ·
bot~s an interesting sequel to Professor Pike 's st udy , a letter signed by
IIUbr Prof~ssors Vess~y ~nd Pike as well as two other researchers and
fo IShed m the followmg 1ssue of Lancet, announced that they were joining
in rces to conduct a large case control study of breast cancer and the Pill
Young women in the U .K.
ember, 1985
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The Neoplasia of the Cervix Study
The Oxford-based group carried out a 10-year ~ollowup of
women who entered the Oxford-FPA contraceptive stu_d_y wl
Pill and 3,154 parous women who entered the ~tudy whlie u
to determine the incidence of biopsy-proven cervical neoplas1 <.
of invasive cancer , which were of squamous _typ~, occurred
the oral contraceptive group. Both carcinoma-m-s_Itu and cer~
also occurred more frequently in this group than m those usr
incidence for all three forms of neoplasia combined, rose fran-,
woman-years in those with up to two years Pill-use to 2 .2 per
years in those with more than eight years Pill use . There w a ~
among IUD users , where the rate remained c~nsta~t , aroun
woman-years. The great majority of cases of mvas1ve cancei
by means of cervical sme~rs. The agwegated data for all f01
neoplasia provided considerable ev1d~nce for an assoCiat
contraceptive use ~ a disturbing find1?g.
.
Vessey and colleagues had already pomted out fro~ result,
FPA study published in 1978 that the use of the ~mphrag .
protection against cervical neoplasi~ and that all SIX warne
in whom invasive cancer of the cervix had developed at that
using the Pill. 4 9 Hence , women using a ~iaphragm .ar::: un
a comparison group in view of the relatively low mc1der
neoplasia among them.
.
Unfortunately data about age at first intercourse and nu n
partners were not collected f~r the women .under study . W (
durations of Pill use were slightly more hkely to be hea\
to have married and had their first full term pregnane~ at an
women with short durations of use . Similar small d1ffere•

8 parous
·1sing the
an IUD,
! 13 cases
vomen in
dysplasia
•J Ds . The
per I ,000
;O woman·mch trend
per I ,000
·e
1 detected
of cervical
with oral
the Oxford
, ight offer
n the study
e, had been
,sfactory as
of cervical
rs of sexual
·n with long
makers and
1rly age than
.:s were al so

apparent in the IUD group.
.
.
. ·· fie estrogen
h p·ll.
Cervical neoplasia was not found to be associated w1th a sr ~ '
. I ar d ose of es t.rogen or bl •Jd oft. he oral
I
or progestogen or with any part1cu
A large number of epidemiological studies conce n~d Wldt orne
· of cervica
· 1 neap 1asia
· have
·5
contraception and the nsk
. . been 1 •tollshe
·.· . . n between
showing negative results while others showed a positive asSOL l:ltiOI -term
· stu d'Ies me
· 1ud e d ven• tew ong been
risk and duration of use . The negative
users of the Pill. In the Oxford group study, no association Wl~~d ha~~ even
apparent if the data had been restricted to women of up to
72 - months of exposure .
.
ak 1·no a
.
u ~ ' IS 01
The possibility that prolonged ora I contracep t 1ve
- ~.:. .
vix eand
contribution to the steadily rising death rates from cancer. of the .c e~ gland
the incidence of invasive cervical cancer and carcino~a-m- sJt~:sentrends
in women under 34 in the last decade, should be borne m mmd.
. sexual
.
In
have generally been considered
to be attn'b uta bl e t o chanoes
e
behavior.
.
.
.
an unfavorable
It is uncertain by what mechamsm the Pill m1ght have
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influence on the risk of cervical neoplasia , but cervical tissues are known
to be responsive to the influence of contraceptive steroids . Furthermore
if the Pill d~es indeed speed up the "transit time" from cervical dysplasi~
to m~re senous neoplasic lesions as described by Stern et al , 5o this might
explam why the Oxford group observed a substantial relation between Pill
use and invasive cancer. The authors conclude that their data offer
cons~derable support to the view that long-term use of the Pill may increase
the nsk of cervical neoplasia , while not overlooking the influence of sexual
factors. They recommend that women who have accumulated more than
say, four years of Pill use should regularly have cervical smears to enabl~
serious disease to be detected and treated while it is curable.
. Now, almost two years later , the significance of the study by Vessey and
h1s colleagues remains , although attempts have been made to discredit it
on the grounds that it did not identify age at first intercourse and numbers
of sexu.al partners. Early age at first intercourse is recognized as an important
factor m the etiology of neoplasia of the cervix , while the sexual hi story
of male co~sorts has also come to be accepted as of considerable significance.
The possible confounding effect of cigarette smoking , which was unknown
as a co-factor in cervical neoplasia at the time the Oxford study began, has
also been put forward to weaken the impact of its findings.
Further evidence in support of a Pill-cervical neoplasia hypothesis has
come from. a ~HO study , largely based on women in developing countries
who~ prehmmary findings show an increase in the relative ri sk for invasive
c~rcmoma of the cervix in women who have ever used the Pill. The relative
nsk of .1. ~ 9 for ever-users increased to I . 53 after five years of Pill use . 5 1
The .hm1ted levels of screening procedures for cervical cancer in developing
~ountnes was considered important as it overcame the problem of a bias
10
favor of early diagnosis in Pill-taking women .who tend to make frequent
use of these procedures in countries where they are more readily available .
A ~nly 31% of the cases gave a history of multiple sexual relationships .
Hs 10 the Oxford study, information on cigarette smoking was not ~ollected.
ow~ver the researchers pointed out that this is unlikely to be an important
~ndtnbuting factor. Cigarette smoking is uncommon among the older womeri
In evelo ·
·
Th
~mg count.nes who made up the bulk of those studied in this survey.
e Weight of evidence from what are now numerous studies dealing with
1
io on~ed use of the Pill and the development of neoplasia of the cervix
The implication of this for women currently using the Pill
hosconsiderable.
Wever is
h
.
.
.
,
e
' somew at uncertam because the findmgs are based m part on
~pos~re to preparations which contained higher doses of estrogens and
ogest_ogens than many products now in use .
theA~~Jth the findings showing the cardiovascular risks associated with taking
stUd III, efforts ~a~e been made to undermine the findings of this WHO
in t~ ~y em~has1zmg the importance of cigarette smoking as a co-factor
lhe Pill :usatiOn of cance~ of the cervi~. ~~ seems that th~ protagonists of
ttl
ould have us believe that the Pill 1s harmless and 11 1s only a matter
"~ persu d'
a mg women not to smoke . There does not appear to be any doubt ,
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however, that cigarette smoking and taking the Pill are a
combination. 52 1 53

~ tty

lethal

. 1970 that DES m
· mothers had caused gen ital
With the news m
. . cancer
f an
in their daughters the scenario was set for the eventual recogmtwn
e
association betwe~n the Pill and cancer. By the mid 1970s, the occurr~n~n
of new growths of the liver, albeit mostly benign , had already e
10
discovered . These were related , not surprisingly , to length of exposure
· vered
the Pill.
About the same time, the news that endometrial cancer had been dtsco gen
in women taking sequential oral contraceptives containing high dose esdtro ..aJ
·
d ta
. t~ withthat
ra\•all
and a weak progestogen, demethisterone, caused the tmme
of Pills of this type from the market. However 1t was rea lized

estrogens seemed to increase the risk of endometrial cancer, irrespective
of their formulation or mode of administration.
By the late 1970s, the etiology of breast and cervical neoplasia had become
much clearer. The work of Pike and Passenbarger and their colleagues
highlighted the possible effect of the Pill in the cause of breast cancer.
Although large epidemiological trials appeared to show that the Pill reduced
benign breast disease, many clinicians gained the opposite impression. As
time went by, more women entered long-term categories of Pill-taking , or
even just aged to the point where carcinogenic agents could exert their effect.
The most recent findings of Professor Pike's research put the spotlight
square'Iy on women who had taken high potency progestogen Pills from
an early age, drawing attention to the concentration of the Pill 's carcinogenic
effects in adolescence and early adulthood . They al so showed that
progestogens, as well as estrogens , had carcinogenic potential.
The rapidly rising incidence of cervical neoplasia in young women , at
a time when mortality from this disease in older women was declining ,
worried the epidemiologists. The etiology of cervical cancer is complex
and multifactorial , involving such factors as early commencement of
intercourse, multiplicity of partners who themselves may have been
promiscuous , viral infections , with Herpes virus II and the Papilloma virus
acting as cofactors ; and now the recognition of an association between
cigarette smoking and cervical cancer . Meanwhile , the Pill during the late
1970s had entered the list , gradually establishing its claim to be recognized
as an important etiological factor.
Finally, Vessey and his colleagues from Oxford confirmt>d the findings
of others . As the wncet editorial said , in commenting on their recent paper:
"The relation reported by them and others of an increasing incidence of
cervix cancer with increasing duration of oral contraceptive .use is strong
and consistent and the progression of dysplasic lesions to in-situ carcinoma
seems to be accelerated by the Pill '' . 56
The effect of the Pill in causing thrombo-embolism, stroke and heart
a~cks, together with its disturbance of lipid metabolism , are well known.
Cigarette smoking, although the mechanism of its action is obscure, is clearly
recognized for its synergistic action in increasing the incidence of cardiovascular pathology in women on the Pill . It is of more than passing interest
that cigarette smoking has now taken its place as a contributing factor in
lleoplasia of the cervix. It remains to be seen whether there is a similar
synergism of action with the Pill in this area .
That the Pill could theoretically be an important cause of immuno~ression offers an interesting area for research in the immediate future .
Ellen Grant has said: "Most women who are allergic to the 20th century
~e previous Pill users . " 57 The Pill ' s di sturbance of li ver function could
lllterfere with enzyme removal of mutagens and carcinogens.
The responsibility for the harmful effects of prescribing the Pill for
adoleseents needs to be sheeted home to those in our community who openly
and consistently advocate it on the grounds of being " realistic " towards
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Smoking and Cervical Cancer
An association of cigarette smoking and cervical neoplasi::• ts recently
been recognized . A study by Trevathan et al in the U.SY has sl· m cigarette
smoking to be significantly associated with carcinoma-i r tu, severe
dysplasia and mild to moderate dysplasia with relative risks o .6, 3.3 and
2.4 respectively. Cumulative exposure to cigarette smoking ; measured
by pack-years smoked) was strongly related to risk of the .:onditions.
ks of 12.7,
Women with 12 or more pack-years of exposure had relative
10.2 and 4.3 respectively for the three conditions , with some idence that
the risk was greatest in women who began smoking in theit .rly teenage
years.
Generally the results of this survey support the data from pt ous studies.
of cigarette
It is suggested that cervical cells may be exposed to compon
smoke that are absorbed into the blood and then secreted r the cervical
epithelium .
The possibility of a causal association between cigarettt making and
cervical neoplasia does not exclude the possible, or even e: ttial , role of
other factors such as herpes simplex type II and multiple s• J al partners.
Perhaps the cervical epithelium, especially while undergoi nf , 1e metaplasic
changes of puberty, is particularly sensitive to the carcinog, .., of cigarette
smoke . Alternatively a systematic effect of smoking , cone vably related
to vitamin A metabolism , could be the mechanism.
By way of conclusion I could do no better than to quote 1 ->m the JAMA
editorial on the subject of smoking and cervical cancer :
.k
"Cervical carcinoma in situ is a disease of young w men. The ns
imparted by smoking is especially large for young wome n
iv~n that ~he
treatment for this disease may result in sterility it is obvious that m addtuon
to jeopardizing their lives , smoking has resulted in an inability to bear
children for thousands of women . " 55
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the reeds of the young. It seems that, to them, the ultimate evil
whi'h is to be avoided at all costs, whatever the conseq w
advocates feel that parental rights should be overridden and t
floUled, twisted or changed; that the young must have thei r
it now , unrestricted , but always " protected" against pregna·
is time , in the interests of the health of the women of our n
long the guinea pigs of the oral contraceptive industry, fo r
of this disastrous policy.

The Centres for Disease Control Cancer and Steroid He
Oral Contraceptive Use and the Risk of Endometri

1regnancy
~s. Those
law either
and have
. Surely it
1n, for too
eappraisal

lOne Study

ancer

(lAMA 1983 . 249. pp. 1600-1604)

This study showed a protective effect for women
1 had used
combination oral contraceptives. (OC) for at least 12 mont h heir relative
risk being 0.5 that of never users. The protective effect w : nost notable
for and largely confined to nulliparous women, whose ri
.:as only 0.4
that of nulliparous never users. Thi s has not been previo y reported.
However , users of sequential OCs and all other OC s we r .t greater ri sk
of endometrial cancer developing than never users , with
r, rat ios (RR)
of 2. I and I . 8 respectively . It appears that at least six day. ( progestogen
treatment per month are necessary for it to exert its protecti d"fect agawst
the carcinogenic effects of the estrogen of the Pill.
ld
The authors estimated that 39,000 women with endometr: : cancer wo~
be diagnosed in the U.S. in 1982 with 3,000 deaths, th .. ; J isease havwg
the th.ir? highest inc.idence of all cancers. It was considen ' that more t~
40 million women m that country have used OCs. Appr ,Jmately 2. f
0
potential new cases of endometrial cancer would be avcn L·d by the use
combination OCs in 1982 , according to the authors of the report.

The Centres for Disease Control Cancer and Steroid Hormone StudY
Long-Term Oral Contraceptive Use and the Risk of Breast Cancer
(lAMA 1983 . 249. pp. 1591-1595)
.l b
ore than
The authors of this report state that OCs have bee n useu Y m
er
25 million women in the U.S . and I 50 million world wide. Breast ~~~se
is the leading cause of cancer mortality among women in the U. S.. the IS
affecting 7% of American women.
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Most pu?lished studies of the effects of OC use on breast cancer were
conducted m the early 1970s and hence were unable to look at the influence
of long-ter.m OC use or the delayed effects of OC use on the risk of breast
cancer, satd the authors.
This study reports the initial 6.months of a 25 month study based on data
for 689 women with newly diagnosed breast cancer and 1,077 controls.
'f?e women were aged 20 to 54. Those with breast cancer, when compared
Wt~h controls , were more likely to be nulliparous, be older when their first
child was .born, have a history of breast cancer in first degree relatives
(mother, sts~er, daughter) and a history of benign breast disease. They were
also more likely to be premenopausal.
c Compared with women who never used OCs , the relative risk of breast
,:~ce~ for women who used the Pill for at least one month sometime in
et~ Itves was 0.9 . The duration of OC use , up to II years or more did
not mfluence a woman's risk of breast cancer.
'
A lack of association between OC use and the risk of breast cancer was
not.ed for women of all ages studied . Even long-term use (II years or more)
:~tch beg~n more than 15 years ago, did not alter the risk . Women who
1./wthe Ptll before their first full term pregna.ncy showe? a risk ratio of
mat ~en c.ompared to controls . The authors dtd not constder this to be a
bec:~~ally mcr~a~ed risk , but suggested fu~the~ analy~es of such cases b
e of thetr tmportance . Use of the Ptll dtd not mcrease the risk of
reabst cancer among women with benign breast diseas~ or a family history
0 f reast cancer.
b The authors make no claims of any cases of breast cancer being averted
Y use of the Pill .

The Centres of Disease Control Cancer and Steroid Hor.mone Study
Oral Contraceptive Use and the Risk of Ovarian Cancer
(lAMA 1983 . 249 . pp . 1596-1599)
Ovarian
· cause of cancer mortality among
wome
. caneer .ran ks as the fiourth Ieadmg
10
will n the U.S . An estimated 18,000 cases and II 400 attributable deaths
.
. 1983 . Almost' one-thtrd
. of the cases
w·u occur among A mencan
women m
a~ro~c~r among women aged 20 to 54 years. Pregnancy appears to exert
can ecttve effect, several studies having noted an increased risk of ovarian
~er among women of low parity .
lbe fie authors report their analysis of ovarian cancer data collected during
diagntrst diO months of a study of 179 women, aged 20 to 54 with newly
· mtact
.'
.
Co ose ovarian
. cancer, compare d to I ,642 women wtth
ovanes.
lobe mpared Wtth controls, women with ovarian cancer were more likely
llld t~ohunger th~n 30 years of age, to have never married or been pregnant
The ave a dtagnosed infertility problem.
~elo a.uthors found that the age-adjusted relative risk of ovarian cancer
Pmg for ever-users compared with never-users was 0.6, the risk
. 1985
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who had
decreasing with increasing duration of OC use to 0.4 in woP
o persist
used the Pill for five yea rs or more. This lower risk appea
long after OC use ceased .
d by the
The a uthors consider that whether ovarian cancer is c
tV
e theory
" incessant ovulation " of the nulliparous woman or by the altc
Jmote
its
that high levels of circulating pituitary gonadotrophi n-,
'
ill
, which
development , both are cons istent with a protective effect of '
both inhibits ovulation a nd suppresses gonadotrophin rete;
20 to 54
They estimate that the incidence of ovarian cancer in w
rher
words
might be about 30 % highe r if women had nev er used OCs .
averted
in
about I , 700 cases of ova ria n cancer in thi s age g roup wii
m iology of
1983 by the use of the Pill . Further investi gation of the c
ed in thei r
ovan an cancer and its re lati onship to OCs is clearl y wa
opm10n .
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